Olmesartan Comp Ratiopharm (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan Comp Ratiopharm, is an Angiotensin II receptor blocker (ARBs) presented as a oral tablet for systemic use. It treats hypertension and may be combined with a diuretic in adults.

GNH USA supplies Olmesartan Comp Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Comp Ratiopharm is an ARB that lowers blood pressure by acting on the renin‑angiotensin system. - Hypertension: Improves systolic and diastolic blood pressure control. - Heart failure: Reduces workload of the heart when used with other guideline‑recommended therapies. - Diabetic nephropathy : Slows the progression of renal damage in type 2 diabetes patients on stable ACE‑inhibitor or ARB therapy. - Post‑cardiac surgery recovery : Helps maintain target blood‑pressure levels during post‑operative care. - Chronic kidney disease (CKD): Assists in blood‑pressure management to protect renal function and reduce protein uria

Common Side Effects: - Dizziness. - Headache. - Fatigue. - Cough . - Upper upper upper  a -   t 

-  .

Serious or Rare Side Effects: - Angio . -   . -  

Olmesartan Comp Ratiopharm requires  g  t \\